Objective.-To review the role of RET mutation analysis in the diagnosis of
multiple endocrine neoplasia type 2 (MEN 2) and in presymptomatic screening
for this disorder.
Data Sources.-Review of the medical literature and current clinical practic
e.
Conclusions.-RET mutation analysis is a sensitive and specific test for MEN
2. It plays a pivotal role in the diagnosis and management of patients and
families with MEN 2 and in the individual who presents with an apparently
sporadic medullary thyroid carcinoma or pheochromocytoma. These disorders m
ay first come to the attention of either the anatomic or clinical pathologi
st, who has the opportunity to see that appropriate testing is done. As wit
h any familial disease, professional genetic counseling is an important par
t of the care of these patients.